Answers: 1. >10% 2. CCUS. Evidence so far suggest most patients will develop a haem malig. during f/up (https://t.co/m9ahQN5vX0) 3. SF3B1 4. Erythopoietin. This pt has IPSS Int-1 MDS. In UK, ESA recommended for symptomatic anaemia in low risk MDS. 24 wk
RT @BloodJournal: Gene mutations can identify myeloid malignancy in patients with unexplained cytopenias https://t.co/EunyyH1w69 https://t.…
RT @BloodJournal: Gene mutations can identify myeloid malignancy in patients with unexplained cytopenias https://t.co/EunyyH1w69 https://t.…
RT @BloodJournal: Gene mutations can identify myeloid malignancy in patients with unexplained cytopenias https://t.co/EunyyH1w69 https://t.…